Skip to main content

Want a detailed portfolio tracker?

Mannkind (MNKD) P/E (2011 - 2026)

Mannkind (MNKD) P/E from Mar 31, 2011 to Jul 20, 2026. The TTM Mannkind (MNKD) P/E is -51.42. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mannkind (MNKD)

YearP/EChange
2026-51.42-117.86%
2025287.85+340.07%
202465.41-312.61%
2023-30.76+123.13%
2022-13.79+2.05%
2021-13.51+6.31%
2020-12.71+158.32%
2019-4.92+178.67%
2018-1.77-138.06%
20174.64-50.71%
20169.41-301.85%
2015-4.66-55.25%
2014-10.42+20.99%
2013-8.61+284.36%
2012-2.24-14.23%
2011-2.61N/A

Comparison Mannkind (MNKD) P/E with competitors

Mannkind (MNKD) P/E is -51.42.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.15%
FGENFibroGen Inc0.24-100.47%
CHRSCoherus Biosciences Inc0.85-101.65%
FBIOFortress Biotech Inc0.95-101.85%
ORMPOramed Pharmaceuticals Inc1.50-102.92%
AGENAgenus Inc3.01-105.85%
INVAInnoviva Inc3.15-106.13%
VXRTVaxart Inc3.55-106.90%
CRMDCorMedix Inc3.63-107.06%
CVACCureVac N.V.4.45-108.65%
GLPGGalapagos NV4.86-109.45%
SRPTSarepta Therapeutics Inc4.88-109.49%
ABEOAbeona Therapeutics Inc5.39-110.48%
ABUSArbutus Biopharma Corp5.60-110.88%
ZVRAZevra Therapeutics Inc5.89-111.45%
SPROSpero Therapeutics Inc6.23-112.11%
CGENCompugen Ltd6.31-112.28%
RIGLRigel Pharmaceuticals6.87-113.36%
SLXNSilexion Therapeutics Corp7.30-114.19%
OMEROmeros Corporation9.26-118.01%
AUPHAurinia Pharmaceuticals Inc9.58-118.64%
PLXProtalix BioTherapeutics Inc10.89-121.18%
ACADAcadia Pharmaceuticals Inc11.73-122.81%
TBPHTheravance Biopharma Inc12.26-123.85%
ADMAAdma Biologics Inc12.42-124.15%
HRMYHarmony Biosciences Holdings Inc13.82-126.88%
SABSSAB Biotherapeutics Inc14.14-127.49%
NAGENiagen Bioscience Inc14.82-128.82%
INCYIncyte Corp15.82-130.77%
REGNRegeneron Pharmaceuticals Inc15.86-130.84%
PBYIPuma Biotechnology Inc17.32-133.68%
CPRXCatalyst Pharmaceuticals Inc17.44-133.92%
EXELExelixis Inc17.54-134.11%
TGTXTG Therapeutics Inc18.97-136.89%
MDXGMimedx Group Inc20.55-139.97%
XOMAXOMA Royalty Corp22.87-144.49%
ARGXArgen X SE24.30-147.26%
CTMXCytomX Therapeutics Inc24.82-148.27%
XOMAOXOMA Royalty Corp25.34-149.29%
HALOHalozyme Therapeutics Inc25.62-149.83%
XOMAPXOMA Royalty Corp25.67-149.92%
VRTXVertex Pharmaceuticals Inc27.99-154.45%
RPRXRoyalty Pharma plc - Class A28.69-155.79%
SLNOSoleno Therapeutics Inc29.02-156.43%
ASNDAscendis Pharma A/S30.09-158.51%
LGNDLigand Pharmaceuticals Inc - Class B37.91-173.73%
APLSApellis Pharmaceuticals Inc39.02-175.89%
BMRNBiomarin Pharmaceutical Inc42.21-182.10%
KRYSKrystal Biotech Inc45.34-188.19%
ONCBeiGene Ltd69.54-235.25%
PHARPharming Group N.V.75.03-245.91%
TECHBio-Techne Corp101.96-298.29%
VCELVericel Corp109.92-313.78%
ALNYAlnylam Pharmaceuticals Inc117.96-329.42%
GMABGenmab140.29-372.84%
TLXTelix Pharmaceuticals Ltd162.15-415.36%
CORTCorcept Therapeutics Inc212.86-513.98%